Title : Combining yttrium 90-labeled ibritumomab tiuxetan with high-dose chemotherapy and stem cell support in patients with relapsed non-Hodgkin's lymphoma.

Pub. Date : 2004 Oct

PMID : 15498146






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Targeted radioimmunotherapy, including yttrium 90-labeled ibritumomab tiuxetan (Zevalin) and iodine I 131 tositumomab (Bexxar), has the potential to increase the cure rate for patients with CD20+ B-cell malignancies who are undergoing autologous hematopoietic stem cell transplantation. ibritumomab tiuxetan keratin 20 Homo sapiens